1-(4-BROMOPHENYL)CYCLOPROPANECARBOXAMIDE, 95.0%, 1g

ETHYL 2-CYANO-3-METHYLBUTANOATE, 95.0%, 1g

trans-Hexen-2-al, min 98.5%, for synthesis, 25 ml, glass packaging

(S)-2-Acetamido-3-mercaptopropanoic acid, 96.0%, 100mg

2,3,4,7-tetrahydro-1H-isoindol-1-one, 95.0%, 500mg

3-chloro-1,5-dimethyl-1H-1,2,4-triazole, 95.0%, 1g

tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, 95.0%, 100g

2-Bromo-4,5,6,7-tetrahydrothieno[3,2-c]pyridine, 97%, 1g

N-(4-Cyclopropyl-6-ethylpyrimidin-2-yl)-5-fluorobenzofuran-2-carboxamide, 98%, 250mg

2-Hydrazinyl-4-methylbenzo[d]thiazole, 95.0%, 5g

1-(Hydroxyimino)-2-(2-nitrophenyl)ethylamine, 95.0%, 1g

((2-fluorophenyl)sulfonyl)proline, 95.0%, 500mg

4-(Morpholinomethyl)benzonitrile, 95.0%, 5g